tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Developments in Rocket Pharmaceuticals’ KRESLADI Gene Therapy Boost Buy Rating
PremiumRatingsPromising Developments in Rocket Pharmaceuticals’ KRESLADI Gene Therapy Boost Buy Rating
16d ago
Promising Future for Rocket Pharmaceuticals: Buy Rating Affirmed on Kresladi’s Progress and Potential
Premium
Ratings
Promising Future for Rocket Pharmaceuticals: Buy Rating Affirmed on Kresladi’s Progress and Potential
16d ago
Promising Future for Rocket Pharmaceuticals: Buy Rating Backed by FDA Progress and Clinical Success
Premium
Ratings
Promising Future for Rocket Pharmaceuticals: Buy Rating Backed by FDA Progress and Clinical Success
16d ago
Rocket Pharmaceuticals Board Member Resigns in September
PremiumCompany AnnouncementsRocket Pharmaceuticals Board Member Resigns in September
27d ago
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
Premium
The Fly
No jobs report amid shutdown, Apple pulls ICEBlock from App Store: Morning Buzz
27d ago
Rocket Pharmaceuticals price target lowered to $7 from $9 at Leerink
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $7 from $9 at Leerink
27d ago
Rocket Pharmaceuticals director buys $34.1K in common stock
PremiumThe FlyRocket Pharmaceuticals director buys $34.1K in common stock
2M ago
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Affirmed Amidst Advancements in RP-A501 Study
Premium
Ratings
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Affirmed Amidst Advancements in RP-A501 Study
2M ago
Rocket Pharmaceuticals CFO Aaron Ondrey resigns to pursue other opportunities
Premium
The Fly
Rocket Pharmaceuticals CFO Aaron Ondrey resigns to pursue other opportunities
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100